Two stocks in Healthcare
Pfizer vs UnitedHealth Group: profit, growth, debt and price compared
Pfizer is stronger on 4 of 7 figures: profit margin, price for its expected profit, dividend and price trend. UnitedHealth Group is stronger on 2: sales growth and debt.
Save both stocks to your watchlist and revisit their latest fundamentals.
| PfizerPFE | UnitedHealth GroupUNH | |
|---|---|---|
| Net margin | Stronger: 6.3% | 3.5% |
| Revenue growth, past year | −0.43% | Stronger: −0.41% |
| Debt to equity | 71.0% | Stronger: 70.4% |
| Forward P/E | Stronger: 9.5× | 15.0× |
| Dividend yield | Stronger: 6.13% | 2.59% |
| Analysts | Buy · 26 | Buy · 25 |
| From its 200-day average | Stronger: +6.1% | −7.8% |
Share price over the past year
- Pfizer+10.3%
- UnitedHealth Group+11.6%
18 Nov 202518 Nov 2026
Pfizer or UnitedHealth Group: which is stronger?
- PFE
Which is more profitable?
Pfizer keeps more of each sale as profit: 6.3% against 3.5%.
- UNH
Which is growing its sales faster?
UnitedHealth Group is growing its sales faster: −0.41% over the past year, against −0.43%.
- UNH
Which has borrowed less?
UnitedHealth Group has borrowed less: its debt is 70.4% of what its shareholders own, against 71.0% for Pfizer.
- PFE
Which costs less for the profit it is expected to make?
Pfizer costs less for the profit it is expected to make: 9.5× its forward earnings, against 15.0×.
- PFE
Which pays more in dividends?
Pfizer pays more back in dividends for what a share costs: 6.13% a year, against 2.59%.
Which do analysts rate higher?
Analysts rate both the same: Buy.
- PFE
Which is in the stronger price trend?
Pfizer's price is in the stronger trend: 6.1% above its 200-day average, against 7.8% below.
What each company does
PFEPfizer
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
Reports results on 2 February 2027
UNHUnitedHealth Group
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally.
Reports results on 12 January 2027
This comparison is just the starting point.
Discover opportunities, understand companies and compare investments in one place. See how StratDeck works
Keep researching
Where next
More comparisons
Free email
Up to speed in minutes, four times a week
Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.
Early access
Become a StratDeck founding user
Use StratDeck, tell us what's missing, and help decide what we build next.
100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.